cetylpyridinium chloride anhydrous has been researched along with Muscular Atrophy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romanello, V; Sandri, M; Sartori, R | 1 |
| Holeček, M | 1 |
| Giannaki, CD; Hadjigeorgiou, GM; Karatzaferi, C; Koukoulis, GN; Koutedakis, Y; Lavdas, E; Liakopoulos, V; Sakkas, GK; Stefanidis, I; Tsianas, N | 1 |
| Candow, DG; Forbes, SC; Little, JP | 1 |
3 review(s) available for cetylpyridinium chloride anhydrous and Muscular Atrophy
| Article | Year |
|---|---|
Mechanisms of muscle atrophy and hypertrophy: implications in health and disease.
Topics: Animals; Disease; Health; Humans; Hypertrophy; Muscle Development; Muscular Atrophy; Signal Transduction | 2021 |
Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.
Topics: Animals; Cachexia; Dietary Supplements; Health; Humans; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Sarcopenia; Valerates; Wasting Syndrome | 2017 |
Exercise and nutritional interventions for improving aging muscle health.
Topics: Adult; Aging; Diet Therapy; Exercise; Exercise Therapy; Health; Humans; Models, Biological; Muscles; Muscular Atrophy; Nutritional Physiological Phenomena; Sarcopenia | 2012 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Muscular Atrophy
| Article | Year |
|---|---|
Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome.
Topics: Body Composition; Female; Health; Humans; Male; Middle Aged; Muscular Atrophy; Quality of Life; Renal Dialysis; Restless Legs Syndrome; Sleep; Surveys and Questionnaires; Uremia | 2011 |